Michael Paul Pieper
3PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 05, 2025
A novel soluble guanylate cyclase activator, avenciguat, in combination with empagliflozin, protects against renal and hepatic injury in diabetic db/db mice.Nisha Sharma, Wenjin Liu, Xiao-Qing E Tsai
|May 23, 2024
Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome.Mengyuan Ge, Judith Molina, Ian Tamayo
|Mar 18, 2023
The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice.Jungmi Choi, Naoki Matoba, Daiki Setoyama
Pageof 1
Frequent Collaborators
1 joint publications
Wenjin Liu
1 joint publications
Anna Tang
1 joint publications
Yufeng Huang
1 joint publications
Motoko Yanagita
1 joint publications
Masamichi Yamamoto
1 joint publications
Mengyuan Ge
1 joint publications
Ian Tamayo
1 joint publications
Guanshi Zhang
1 joint publications
Jin-Ju Kim
1 joint publications
Rachel Njeim
